2026 Brain and Spine Symposium Highlights Advances Across the Neurosciences - Summary - MDSpire

2026 Brain and Spine Symposium Highlights Advances Across the Neurosciences

Over two days, specialists across neurology, neurosurgery and related subspecialties came together to discuss advances in stroke care, epilepsy, movement disorders, neurodegenerative disease, neuro-oncology, brain and spine surgery, interventional pain management and emerging technologies.

  • By

  • May 21, 2026

  • 1 min

Share

Objective:

To discuss recent advancements in various fields of neuroscience and their implications for patient care, particularly in enhancing treatment outcomes.

Key Findings:
  • Collaboration across disciplines is essential for improving patient care.
  • Emerging technologies are playing a significant role in advancing neuroscience, particularly in treatment planning and execution.
Interpretation:

The symposium emphasized that interdisciplinary collaboration leads to improved patient outcomes in neuroscience through shared knowledge and resources.

Limitations:
Conclusion:

The event served as a vital platform for clinical insight, education, and connection among professionals, significantly advancing the field of neuroscience.

Original Source(s)

2026 Brain and Spine Symposium Highlights Advances Across the Neurosciences

  • by

  • May 21, 2026

Related Content

MRI May Define Two Distinct Migraine Phenotypes

Patients with greater migraine burden showed widespread connectivity changes and lower cortical volume.

Baptist Health Foundation Presents Endowed Chair Ceremony for Aviva Abosch, M.D., Ph.D.

Aviva Abosch, M.D., Ph.D., a neurosurgeon at Baptist Health Miami Neuroscience Institute, part of Baptist Health Brain and Spine Care, was installed as the Esernia Endowed Chair in Surgical Treatment of Adult Epilepsy and Movement Disorders.

  • by

  • May 21, 2026

  • 5 min
CGRP Therapies Reduced Migraine Days

Systematic review found high-certainty evidence for several calcitonin gene–related peptide–targeted therapies